Ole Maaløes Vej 3, DK-2200 Copenhagen N Denmark | VIA EDGAR |
September 22, 2020
U.S. Securities and Exchange Commission
Office of Life Sciences
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
| Attn: | Mr. Alan Campbell |
Ms. Christine Westbrook |
Mr. David Burton |
Ms. Mary Mast |
| Re: | Orphazyme A/S |
Registration Statement on Form F-1, as amended |
File No. 333-248607 |
Acceleration Request |
| Requested Date: | Thursday, September 24, 2020 | |
| Requested Time: | 4:00 P.M. Eastern Daylight Time |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 (File No. 333-248607) (the “Registration Statement”) to become effective on September 24, 2020, at 4:00 p.m., Eastern Daylight Time, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff (the “Staff”).
Once the Registration Statement has been declared effective, please orally confirm that event with Josh Kaufman of Cooley LLP (212) 479-6495, counsel to the Registrant, Alison Haggerty at (212) 479-6596 or Divakar Gupta at (212) 479-6474.
| Very truly yours, | ||
| Orphazyme A/S | ||
| By: | /s/ Kim Stratton | |
| Kim Stratton | ||
| Chief Executive Officer | ||
| cc: | Anders Vadsholt, Orphazyme A/S | |
| Alison Haggerty, Cooley LLP | ||
| Divakar Gupta, Cooley LLP | ||
| Mark Ballantyne, Cooley LLP | ||
| Ilir Mujalovic, Shearman & Sterling LLP |
[Signature Page to Acceleration Request]